Michael Hölzel
Impact in
- Oncology top 1%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
- Immunology top 2%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
Papers in
- Oncology 36
- Cancer Immunotherapy and Biomarkers 14
- CAR-T cell therapy research 7
-
- Epigenetics and DNA Methylation 7
- RNA and protein synthesis mechanisms 6
- Co-authors
- Thomas Tüting (12 shared papers)Dirk Eick (13 shared papers)Tobias Bald (14 shared papers)Anton Bovier (1 shared paper)Jennifer Landsberg (9 shared papers)Rohrmoser Michaela (6 shared papers)Elisabeth Kremmer (5 shared papers)Harasim Thomas (6 shared papers)
- Journals
- Journal of Clinical Oncology (5 papers)Cancers (5 papers)Journal of Biological Chemistry (3 papers)Journal for ImmunoTherapy of Cancer (3 papers)Cancer Research (2 papers)
- Partner nations
- GermanyUnited StatesUnited Kingdom
In The Last Decade
Michael Hölzel
97 papers receiving 4.4k citations
Peers
Comparison fields: 5 of 117
- Oncology 1.6k
- Immunology 1.2k
- Cancer Research 501
- Molecular Biology 2.1k
- Neurology 280
Countries citing papers authored by Michael Hölzel
This map shows the geographic impact of Michael Hölzel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Hölzel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Hölzel more than expected).
Fields of papers citing papers by Michael Hölzel
This network shows the impact of papers produced by Michael Hölzel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Hölzel. The network helps show where Michael Hölzel may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael Hölzel, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 100 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 468 | |
| 2 | 2010 | 351 | |
| 3 | 2013 | 213 | |
| 4 | 2014 | 200 | |
| 5 | 2014 | 200 | |
| 6 | 2005 | 162 | |
| 7 | 2017 | 161 | |
| 8 | 2010 | 158 | |
| 9 | 2015 | 157 | |
| 10 | 2011 | 154 | |
| 11 | 2020 | 117 | |
| 12 | 2009 | 115 | |
| 13 | 2007 | 111 | |
| 14 | 2019 | 92 | |
| 15 | 2020 | 91 | |
| 16 | 2017 | 89 | |
| 17 | 2020 | 83 | |
| 18 | 2017 | 78 | |
| 19 | 2007 | 77 | |
| 20 | 2004 | 61 |
About Michael Hölzel
Michael Hölzel is a scholar working on Oncology, Molecular Biology, Immunology, Pulmonary and Respiratory Medicine and Surgery, having authored 100 papers that have together received 4.5k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (14 papers), Immunotherapy and Immune Responses (9 papers), Bladder and Urothelial Cancer Treatments (8 papers), Epigenetics and DNA Methylation (7 papers), CAR-T cell therapy research (7 papers), Brain Metastases and Treatment (6 papers), RNA and protein synthesis mechanisms (6 papers) and Meningioma and schwannoma management (6 papers). The work is most often cited by research in Oncology (1.6k citations), Immunology (1.2k citations), Cancer Research (501 citations), Molecular Biology (2.1k citations) and Neurology (280 citations). Michael Hölzel has collaborated with scholars based in Germany, United States and United Kingdom. Frequent co-authors include Thomas Tüting, Dirk Eick, Tobias Bald, Anton Bovier, Jennifer Landsberg, Rohrmoser Michaela, Elisabeth Kremmer, Harasim Thomas, Malamoussi Anastassia and Marcel Renn. Their work appears in journals such as Journal of Clinical Oncology, Cancers, Journal of Biological Chemistry, Journal for ImmunoTherapy of Cancer and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.